Drdgold (DRDGF) Cash & Equivalents (2017 - 2025)

Drdgold has reported Cash & Equivalents over the past 9 years, most recently at $71.5 million for Q2 2025.

  • Quarterly results put Cash & Equivalents at $71.5 million for Q2 2025, up 154.49% from a year ago — trailing twelve months through Jun 2025 was $71.5 million (up 154.49% YoY), and the annual figure for FY2025 was $71.5 million, up 154.49%.
  • Cash & Equivalents reached $71.5 million in Q2 2025 per DRDGF's latest filing, up from $28.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $163.0 million in Q2 2022 and bottomed at $28.1 million in Q2 2024.
  • Median Cash & Equivalents over the past 5 years was $132.9 million (2023), compared with a mean of $109.9 million.
  • The largest annual shift saw Cash & Equivalents tumbled 78.85% in 2024 before it surged 154.49% in 2025.
  • Over 5 years, Cash & Equivalents stood at $154.2 million in 2021, then rose by 5.71% to $163.0 million in 2022, then fell by 18.47% to $132.9 million in 2023, then crashed by 78.85% to $28.1 million in 2024, then soared by 154.49% to $71.5 million in 2025.
  • Business Quant data shows Cash & Equivalents for DRDGF at $71.5 million in Q2 2025, $28.1 million in Q2 2024, and $132.9 million in Q2 2023.